Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger B Kramer

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Plos One|April 19, 2019
Correction: Systemic Administration of Glibenclamide Fails to Achieve Therapeutic Levels in the Brain and Cerebrospinal Fluid of RodentsCarolina Lahmann, Holger B Kramer, Frances M Ashcroft
Plos One|July 31, 2015
Systemic Administration of Glibenclamide Fails to Achieve Therapeutic Levels in the Brain and Cerebrospinal Fluid of RodentsCarolina Lahmann, Holger B Kramer, Frances M Ashcroft
Biochimica Et Biophysica Acta|May 23, 2012
Detection of ubiquitin-proteasome enzymatic activities in cells: application of activity-based probes to inhibitor developmentHolger B Kramer, Benjamin Nicholson, Benedikt M Kessler, et al.
The FEBS Journal|June 18, 2010
Post-translational modification of the deubiquitinating enzyme otubain 1 modulates active RhoA levels and susceptibility to Yersinia invasionMariola J Edelmann, Holger B Kramer, Mikael Altun, et al.
Chemical Science|June 14, 2021
Probing enzymatic activity - a radical approachNeil C Taylor, Gary Hessman, Holger B Kramer, et al.
Virology Journal|September 22, 2011
Label-free quantitative proteomics reveals regulation of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) and 5'-3'-exoribonuclease 2 (XRN2) during respiratory syncytial virus infectionNicola Ternette, Cynthia Wright, Holger B Kramer, et al.
Nature Protocols|December 15, 2007
Site-selective glycosylation of proteins: creating synthetic glycoproteinsSander I van Kasteren, Holger B Kramer, David P Gamblin, et al.
Chemistry & Biology|December 3, 2013
Deubiquitinating enzyme specificity for ubiquitin chain topology profiled by di-ubiquitin activity probesJoanna F McGouran, Selina R Gaertner, Mikael Altun, et al.
Molecular & Cellular Proteomics : MCP|October 22, 2008
Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteinsMatthew E Cockman, James D Webb, Holger B Kramer, et al.
The FEBS Journal|January 7, 2022
Off-target inhibition of NGLY1 by the polycaspase inhibitor Z-VAD-fmk induces cellular autophagySarah H Needs, Martin D Bootman, Jeff E Grotzke, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Plos One|April 19, 2019
Correction: Systemic Administration of Glibenclamide Fails to Achieve Therapeutic Levels in the Brain and Cerebrospinal Fluid of RodentsCarolina Lahmann, Holger B Kramer, Frances M Ashcroft
Plos One|July 31, 2015
Systemic Administration of Glibenclamide Fails to Achieve Therapeutic Levels in the Brain and Cerebrospinal Fluid of RodentsCarolina Lahmann, Holger B Kramer, Frances M Ashcroft
Biochimica Et Biophysica Acta|May 23, 2012
Detection of ubiquitin-proteasome enzymatic activities in cells: application of activity-based probes to inhibitor developmentHolger B Kramer, Benjamin Nicholson, Benedikt M Kessler, et al.
The FEBS Journal|June 18, 2010
Post-translational modification of the deubiquitinating enzyme otubain 1 modulates active RhoA levels and susceptibility to Yersinia invasionMariola J Edelmann, Holger B Kramer, Mikael Altun, et al.
Chemical Science|June 14, 2021
Probing enzymatic activity - a radical approachNeil C Taylor, Gary Hessman, Holger B Kramer, et al.
Virology Journal|September 22, 2011
Label-free quantitative proteomics reveals regulation of interferon-induced protein with tetratricopeptide repeats 3 (IFIT3) and 5'-3'-exoribonuclease 2 (XRN2) during respiratory syncytial virus infectionNicola Ternette, Cynthia Wright, Holger B Kramer, et al.
Nature Protocols|December 15, 2007
Site-selective glycosylation of proteins: creating synthetic glycoproteinsSander I van Kasteren, Holger B Kramer, David P Gamblin, et al.
Chemistry & Biology|December 3, 2013
Deubiquitinating enzyme specificity for ubiquitin chain topology profiled by di-ubiquitin activity probesJoanna F McGouran, Selina R Gaertner, Mikael Altun, et al.
Molecular & Cellular Proteomics : MCP|October 22, 2008
Proteomics-based identification of novel factor inhibiting hypoxia-inducible factor (FIH) substrates indicates widespread asparaginyl hydroxylation of ankyrin repeat domain-containing proteinsMatthew E Cockman, James D Webb, Holger B Kramer, et al.
The FEBS Journal|January 7, 2022
Off-target inhibition of NGLY1 by the polycaspase inhibitor Z-VAD-fmk induces cellular autophagySarah H Needs, Martin D Bootman, Jeff E Grotzke, et al.
Pageof 5